Whether you’re using PCR or NGS, targeted panels or whole-genome sequencing, mono- or multiplex testing, we have a solution to empower your workflow. Stop by booth #607 to explore and demo some of our products, including QCI Interpret.
Sip, mingle, and connect while gearing up for an exciting weekend of events, which include three QIAGEN-sponsored Corporate Workshops and two QIAGEN Innovation Stage Spotlights.
In a not-to-be-missed talk, Dr. Fergus Couch of the Mayo Clinic will discuss the current challenges and opportunities of liquid biopsy in oncology research.
Meet us at the Innovation Stage on November 1st.
Learn about QIAGEN Clinical Insight (QCI), a flexible clinical decision support suite that is compatible with any NGS platform, running any assay, targeting any indication, including somatic, hereditary, hematological or childhood cancers. During this talk, Dan Richards, Vice President of Biomedical Informatics at QIAGEN and co-founder of Ingenuity Systems, will present a lung cancer case study to show how QCI allows you to optimize and scale your pipeline for the clinical interpretation of genetic variants—from sequence data to report sign-off—without sacrificing accuracy or utility.
We are days away from one of the largest gatherings of molecular pathologists and diagnostic professionals and we couldn’t be more excited to support your path to precision medicine.
Visit us at booth #607 to demo our solutions or chat with our experts.
Learn more at our AMP 2018 event page.
See you in San Antonio!
© QIAGEN 2019. All rights reserved - Trademarks & Disclaimers